A. Potti

Thrombocytopenia associated with c7E3 Fab (abciximab)

R. Levitt, D. Schell, A. Ganti, 2002, Annals of Hematology.

Risk Factors for Deep Venous Thrombosis of the Upper Extremities

D. Pandita, A. Potti, P. Steen, 1997, Annals of Internal Medicine.

Risk Factors for Thrombosis and the Beneficial Effect of Aspirin in Patients with Antiphospholipid Antibodies (aPL).

T. Ortel, K. Hansen, H. Kramm, 2004 .

Severe Evans's syndrome secondary to interleukin-2 therapy: treatment with chimeric monoclonal anti-CD20 antibody

N. Kobrinsky, M. Abdel-Raheem, A. Potti, 2001, Annals of Hematology.

Fludarabine therapy in chronic lymphocytic leukemia-associated severe nephrotic syndrome.

G. Gross, M. Abdel-Raheem, A. Potti, 2000, Haematologica.

Defective myelin lipid synthesis as a pathogenic mechanism of Canavan disease.

D. Jacobowitz, J. Moffett, P. Arun, 2006, Advances in experimental medicine and biology.

Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC): clinical patterns, diagnosis and therapeutic considerations.

S. Mehdi, R. Levitt, M. Abdel-Raheem, 2001, Lung cancer.

Risk factors for deep venous thrombosis of the upper extremities.

D. Pandita, A. Potti, P. Steen, 1997, Annals of internal medicine.